Negative Results Matter: Why Can't We Improve the Treatment of Proliferative Vitreoretinopathy?
- PMID: 28528822
- DOI: 10.1016/j.ophtha.2017.02.020
Negative Results Matter: Why Can't We Improve the Treatment of Proliferative Vitreoretinopathy?
Comment on
-
Slow-Release Dexamethasone in Proliferative Vitreoretinopathy: A Prospective, Randomized Controlled Clinical Trial.Ophthalmology. 2017 Jun;124(6):757-767. doi: 10.1016/j.ophtha.2017.01.021. Epub 2017 Feb 23. Ophthalmology. 2017. PMID: 28237428 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
